Methylprednisolone therapy in a child with unresolving ARDS
Related Experiment Video
Updated: Aug 6, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Lokesh Guglani1, Siddharth Jain, Rakesh Lodha
1Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India.
Abstract:
We report successful use of methyl-prednisolone in a 21-month old child with ARDS that did not improve with conventional therapy. The child improved and could be extubated after 10 days of methylprednisolone therapy. Subsequently, the child was weaned off supplementary oxygen. Methylprednisolone appeared to be safe and effective in a child with unresolving ARDS.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Pulmonary Cycle: Exhalation
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
